Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-21

Clinical Trial Update: Evaluation the Effects of French Maritime Pine Bark Extract on the Clinical Status in Traumatic Brain Injury Patients [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating French Maritime Pine Bark Extract in traumatic brain injury completed Phase 1 and Phase 2 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • French Maritime Pine Bark Extract

Snippet

Sponsor: Mashhad University of Medical Sciences | Conditions: Traumatic Brain Injury | Phase 1, Phase 2 | Status: COMPLETED